2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative
AssigneeTaisho Pharmaceutical Co., Ltd.
InventorsAkito Yasuhara, Kazunari Sakagami, Hiroshi Ohta, Atsuro Nakazato
Life of this patent
Estimating the term…
Loading patent…
AssigneeTaisho Pharmaceutical Co., Ltd.
InventorsAkito Yasuhara, Kazunari Sakagami, Hiroshi Ohta, Atsuro Nakazato
Estimating the term…
One object of the present invention is to provide a drug that is effective in treatments for and prevention of psychiatric disorders and in treatments for and prevention of neurological diseases, inhibiting a Group II metabotropic glutamate receptor. The object is solved by a 2-amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative represented by formula [I]: (wherein R1 and R2 are the same or different, and each represents a hydrogen atom, C1-10alkyl group, etc; X represents a hydrogen atom or a fluorine atom; and Y represents an amino group, —SR3, —S(O)nR7, —SCHR3R4, —S(O)nCHR3R4, —NHCHR3R4, —N(CHR3R4)(CHR5R6), —NHCOR3 or —OCOR7), a pharmaceutically acceptable salt thereof, or a hydrate thereof and so on.
A 2-amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative, a pharmaceutically acceptable salt thereof or a hydrate thereof, represented by formula [I]
A 2-amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative, a pharmaceutically acceptable salt thereof or a hydrate thereof, represented by formula [II]
Dependencies are inferred from the claim text.